(EMAILWIRE.COM, March 14, 2019 ) Therapeutic Drug Monitoring Market growth is largely driven by factors rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies.

In this report, the market has been categorized based on product, class of drugs, technology, end user, and region. On the basis of technology, the therapeutic drug monitoring market is segmented into immunoassay and chromatography & MS. In 2018, the immunoassay segment is expected to account for the largest share of the therapeutic drug monitoring market.

The large share of this segment is mainly due to the increasing incidence of chronic and infectious diseases and technological innovation.

Download PDF:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443

Objectives of the Study:

- To define, describe, and forecast the therapeutic drug monitoring market on the basis of technology, product, class of drug, end user, and regions

- To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

- To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

- To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)

Speak To Our Research Expert:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=155350443

North America is expected to account for the largest share of the global therapeutic drug monitoring market, while Asia Pacific is expected to grow at the highest rate during the forecast period. The dominant share of the North American market is attributed to its well-established pharmaceutical industry, the presence of leading pharmaceutical and biotechnology companies, favorable government funding, and high R&D investments in this region.

The key players operating in the TDM market are F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), and Abbott (US). A majority of leading players in the TDM market focus on both organic and inorganic growth strategies to maintain and enhance their market share in the TDM market.

Request Research Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=155350443